SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-059391
Filing Date
2023-11-06
Accepted
2023-11-06 16:09:49
Documents
71
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rvmd-20230930.htm   iXBRL 10-Q 3231541
2 EX-10.3 rvmd-ex10_3.htm EX-10.3 57301
3 EX-31.1 rvmd-ex31_1.htm EX-31.1 18192
4 EX-31.2 rvmd-ex31_2.htm EX-31.2 18151
5 EX-32.1 rvmd-ex32_1.htm EX-32.1 9204
6 EX-32.2 rvmd-ex32_2.htm EX-32.2 9194
  Complete submission text file 0000950170-23-059391.txt   10789270

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rvmd-20230930_pre.xml EX-101.PRE 330186
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rvmd-20230930_lab.xml EX-101.LAB 462292
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rvmd-20230930.xsd EX-101.SCH 59826
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rvmd-20230930_cal.xml EX-101.CAL 54237
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rvmd-20230930_def.xml EX-101.DEF 184365
65 EXTRACTED XBRL INSTANCE DOCUMENT rvmd-20230930_htm.xml XML 2098741
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39219 | Film No.: 231380057
SIC: 2836 Biological Products, (No Diagnostic Substances)